-
TSBX Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Turnstone Biologics (TSBX)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 24.25 mm | 24.25 mm | 24.25 mm | 24.25 mm | 24.25 mm | 24.25 mm |
Cash burn (monthly) | (no burn) | (no burn) | 6.12 mm | 6.67 mm | (no burn) | 1.31 mm |
Cash used (since last report) | n/a | n/a | 17.25 mm | 18.79 mm | n/a | 3.70 mm |
Cash remaining | n/a | n/a | 7.00 mm | 5.46 mm | n/a | 20.55 mm |
Runway (months of cash) | n/a | n/a | 1.1 | 0.8 | n/a | 15.6 |
13F holders | Current |
---|---|
Total holders | 46 |
Opened positions | 21 |
Closed positions | 8 |
Increased positions | 9 |
Reduced positions | 11 |
13F shares | Current |
---|---|
Total value | 29.40 bn |
Total shares | 14.70 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Orbimed Advisors | 3.10 mm | $8.12 bn |
Versant Venture Capital V | 2.90 mm | $33.05 mm |
FMR | 1.14 mm | $2.97 bn |
Point72 Asset Management | 1.12 mm | $2.93 bn |
Partner Fund Management | 932.35 k | $2.44 bn |
BAC Bank of America | 910.78 k | $2.39 bn |
Citadel Advisors | 684.63 k | $1.79 bn |
Vanguard | 579.00 k | $1.52 bn |
72 Investment | 549.98 k | $1.44 bn |
Sectoral Asset Management | 517.65 k | $1.36 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Jun 24 | Kanya Rajangam | Stock Option Common Stock | Grant | Acquire A | No | No | 2.69 | 12,770 | 34.35 k | 12,770 |
3 Jun 24 | Gould Robert J | Stock Option Common Stock | Grant | Acquire A | No | No | 2.69 | 12,770 | 34.35 k | 12,770 |
3 Jun 24 | Rishi Gupta | Stock Option Common Stock | Grant | Acquire A | No | No | 2.69 | 12,770 | 34.35 k | 12,770 |
3 Jun 24 | Davis Jerel | Stock Option Common Stock | Grant | Acquire A | No | No | 2.69 | 12,770 | 34.35 k | 12,770 |
3 Jun 24 | Waddill William D. | Stock Option Common Stock | Grant | Acquire A | No | No | 2.69 | 12,770 | 34.35 k | 12,770 |